Your first session could change everything
Fabrizio, P., Pozza, F., Pletcher, S
How it works Clinical evidence Comparison with other GLP-1s Market outlook References Further reading Orforglipron, the first promising oral small-molecule GLP-1, is demonstrating weight-loss and metabolic results that could reshape obesity treatment and challenge injectable standards
Mao D, Cao H, Shi M, Wang CC, Kwong J, Li JJ, et al
Its gentle profile makes it popular for lean-muscle preservation during calorie deficits
It also acts as an antioxidant, protecting cells from oxidative damage